More articles from Guideline

You have access
Community cancer programs as strategic alliances: challenges and guidelines for action
A. D. Kaluzny

CMAJ June 01, 1991 144 (11) 1427-1432;
You have access
Cyclosporine monitoring: consensus recommendations and guidelines. Canadian Consensus Meeting on Cyclosporine Monitoring
R. W. Yatscoff

CMAJ May 01, 1991 144 (9) 1119-1120;
You have access
Guidelines for measles control in Canada
CMAJ April 15, 1991 144 (8) 997-1000;
You have access
Report of the Expert Advisory Committee on the Use of Drugs in the Treatment of Abuse and Dependence to Narcotic and Controlled Drugs
CMAJ November 01, 1990 143 (9) 861-865;
You have access
Guidelines for the release of laboratory test results, reports and specimens to patients, interested groups and other institutions. Canadian Association of Pathologists
CMAJ November 01, 1990 143 (9) 847-848;
You have access
Guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence research. Federal Centre for AIDS Working Group on anonymous unlinked HIV seroprevalence
CMAJ October 01, 1990 143 (7) 625-627;
You have access
Maternal serum alpha-fetoprotein screening programs and quality control for laboratories performing maternal serum and amniotic fluid alpha-fetoprotein assays: policy statement. American Society of Human Genetics
CMAJ June 15, 1987 136 (12) 1253-1256;

Pages